Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 46 (10%) | |
| Anticipated shortage: | 15 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 376 (84%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (18%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PAROXETINE | 10MG | TABLET | Resolved | 2021-09-28 | 2021-09-29 | 146277 |
| SIMVASTATIN | 10MG | TABLET | Resolved | 2018-07-09 | 2021-05-06 | 54802 |
| FLUOXETINE | 10MG | CAPSULE | Actual shortage | 2022-07-12 | 2024-05-22 | 164459 |
| BACLOFEN | 10MG | TABLET | Resolved | 2019-01-10 | 2019-01-25 | 71821 |
| BACLOFEN | 10MG | TABLET | Resolved | 2023-07-31 | 2023-11-27 | 200471 |
| BACLOFEN | 10MG | TABLET | Avoided shortage | 2023-12-01 | 2023-12-01 | 212107 |
| AMLODIPINE | 10MG | TABLET | Resolved | 2017-03-14 | 2017-08-18 | 2354 |
| TERAZOSIN | 10MG | TABLET | Resolved | 2017-09-27 | 2017-10-07 | 23666 |
| TERAZOSIN | 10MG | TABLET | Resolved | 2018-06-28 | 2018-10-13 | 53076 |
| TERAZOSIN | 10MG | TABLET | Resolved | 2021-03-10 | 2024-03-02 | 135439 |
| LEFLUNOMIDE | 10MG | TABLET | Resolved | 2019-03-29 | 2019-07-06 | 79973 |
| LEFLUNOMIDE | 10MG | TABLET | Resolved | 2023-07-05 | 2023-09-25 | 197620 |
| OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-09-13 | 2018-11-16 | 21992 |
| OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-03-27 | 2024-03-02 | 79600 |
| OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-04-10 | 2024-05-22 | 224800 |
| RABEPRAZOLE EC | 10MG | TABLET (ENTERIC-COATED) | Actual shortage | 2023-12-26 | 2024-05-08 | 214284 |
| ROSUVASTATIN | 10MG | TABLET | Resolved | 2023-06-22 | 2023-09-06 | 196102 |
| ESCITALOPRAM | 10MG | TABLET | Resolved | 2021-06-09 | 2021-07-18 | 140601 |
| RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-03-19 | 2020-08-05 | 109013 |
| MEMANTINE | 10MG | TABLET | Resolved | 2020-10-20 | 2021-02-11 | 126746 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144029 |
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-12-16 | 2021-12-17 | 151293 |
| INDAPAMIDE | 2.5MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2450 |
| CILAZAPRIL | 2.5MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4918 |
| FENOFIBRATE MICRO | 200MG | CAPSULE | Discontinued | 2017-08-02 | 2017-08-02 | 17972 |
| DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
| RAMIPRIL-HCTZ | 25.0MG 10.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3026 |
| RAMIPRIL-HCTZ | 25.0MG 5.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3032 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| TERAZOSIN | 2MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151281 |
| CLINDAMYCIN | 300MG | CAPSULE | Reversed | 2017-03-31 | 2017-07-31 | 4956 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| TRAMADOL/ACET | 325MG 37.5MG | TABLET | Discontinued | 2020-04-08 | 2020-07-07 | 111524 |
| RISEDRONATE | 35MG | TABLET | Discontinued | 2024-02-28 | 2024-02-29 | 220861 |
| ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4959 |
| ACYCLOVIR | 400MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4942 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| HYDROXYUREA | 500MG | CAPSULE | Discontinued | 2017-04-03 | 2017-04-03 | 5084 |
| AZATHIOPRINE | 50MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4899 |